Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04902274 · ClinicalTrials.gov registry record · NA
Effectiveness of Transcranial Direct Current Stimulation (tDCS).
A NA study, sponsored by Keller Army Community Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT04902274: Clinical Trial NA study, sponsored by Keller Army Community Hospital.
NCT04902274 is a NA study that was terminated before completion, run by Keller Army Community Hospital. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04902274, a NA study, was terminated before completion, sponsored by Keller Army Community Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Reducing pain and recovery of strength and function are major challenges in physical therapy. Transcranial direct current stimulation (tDCS) is a novel intervention that has gained popularity in the rehabilitation of athletic injuries, pain management, and sports performance. Acute application of tDCS has been shown to modulate the perception of effort and fatigue, enhance motor learning, improve endurance performance, and improve muscular power and strength. tDCS has also been shown to reduce pain in patients with chronic pain conditions. Using a double-blind, randomized clinical trial design, we aim to evaluate the effectiveness of tDCS plus standard rehabilitation compared to rehabilitation alone on pain, balance and proprioception, functional performance, and strength following acute ankle inversion sprain. We hypothesize that the group using tDCS will demonstrate superior outcomes in all variables of interest.
Primary Outcome
Numerical Pain Rating Scale assessment of Current, Best 24-hour, Worst 24-hour Pain
Interventions
- OTHER Physical Therapy
- OTHER Transcranial Direct Current Stimulation
- OTHER Sham Transcranial Direct Current Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2020-08-19 |
| Est. Completion | 2021-12-17 |
| Phase | NA |
Why NCT04902274 stopped before completion
NCT04902274 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Physical Therapy is the first listed.
NCT04902274 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04902274 about?
NCT04902274 is a clinical study titled "Effectiveness of Transcranial Direct Current Stimulation (tDCS).". Reducing pain and recovery of strength and function are major challenges in physical therapy. Transcranial direct current stimulation (tDCS) is a novel intervention that has gained popularity in the rehabilitation of athletic injuries, pain management, and sports performance. Acute application of tD...
What is the current status of trial NCT04902274?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2020-08-19. Estimated completion is 2021-12-17.
What interventions are being tested in trial NCT04902274?
The interventions under investigation include: Physical Therapy (OTHER), Transcranial Direct Current Stimulation (OTHER), Sham Transcranial Direct Current Stimulation (OTHER).
Who is sponsoring clinical trial NCT04902274?
This trial is sponsored by Keller Army Community Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04902274's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI